AU2018260865A1 - Multidirectional mucosal delivery devices and methods of use - Google Patents
Multidirectional mucosal delivery devices and methods of use Download PDFInfo
- Publication number
- AU2018260865A1 AU2018260865A1 AU2018260865A AU2018260865A AU2018260865A1 AU 2018260865 A1 AU2018260865 A1 AU 2018260865A1 AU 2018260865 A AU2018260865 A AU 2018260865A AU 2018260865 A AU2018260865 A AU 2018260865A AU 2018260865 A1 AU2018260865 A1 AU 2018260865A1
- Authority
- AU
- Australia
- Prior art keywords
- multidirectional
- methods
- delivery devices
- mucosal delivery
- transmucosal delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Abstract
1: \rbr\Interwoven\NRPortbl\DCC\RBR\14670119_l.docx-2 06/2017 The present invention relates to a pharmaceutical dosage form for transmucosal delivery of an active agent to two or more mucosal surfaces. The dosage form is presented as a transmucosal delivery device. The devices of the invention may include at least two mucoadhesive surfaces. The devices may further include an intermediate layer disposed between the mucoadhesive layers. The pharmaceutical can be incorporated in any one or all of the mucoadhesive layers or the intermediate layer. Upon application, the device adheres to at least two surfaces, providing transmucosal delivery of the drug to at least two surfaces.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2018260865A AU2018260865A1 (en) | 2008-06-23 | 2018-11-07 | Multidirectional mucosal delivery devices and methods of use |
AU2020220105A AU2020220105A1 (en) | 2008-06-23 | 2020-08-19 | Multidirectional mucosal delivery devices and methods of use |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61/074,918 | 2008-06-23 | ||
AU2009271271A AU2009271271A1 (en) | 2008-06-23 | 2009-06-23 | Multidirectional mucosal delivery devices and methods of use |
AU2015203167A AU2015203167A1 (en) | 2008-06-23 | 2015-06-04 | Multidirectional mucosal delivery devices and methods of use |
AU2017203749A AU2017203749A1 (en) | 2008-06-23 | 2017-06-02 | Multidirectional mucosal delivery devices and methods of use |
AU2018260865A AU2018260865A1 (en) | 2008-06-23 | 2018-11-07 | Multidirectional mucosal delivery devices and methods of use |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2017203749A Division AU2017203749A1 (en) | 2008-06-23 | 2017-06-02 | Multidirectional mucosal delivery devices and methods of use |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2020220105A Division AU2020220105A1 (en) | 2008-06-23 | 2020-08-19 | Multidirectional mucosal delivery devices and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2018260865A1 true AU2018260865A1 (en) | 2018-11-22 |
Family
ID=53570972
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2015203167A Abandoned AU2015203167A1 (en) | 2008-06-23 | 2015-06-04 | Multidirectional mucosal delivery devices and methods of use |
AU2017203749A Abandoned AU2017203749A1 (en) | 2008-06-23 | 2017-06-02 | Multidirectional mucosal delivery devices and methods of use |
AU2018260865A Abandoned AU2018260865A1 (en) | 2008-06-23 | 2018-11-07 | Multidirectional mucosal delivery devices and methods of use |
AU2020220105A Abandoned AU2020220105A1 (en) | 2008-06-23 | 2020-08-19 | Multidirectional mucosal delivery devices and methods of use |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2015203167A Abandoned AU2015203167A1 (en) | 2008-06-23 | 2015-06-04 | Multidirectional mucosal delivery devices and methods of use |
AU2017203749A Abandoned AU2017203749A1 (en) | 2008-06-23 | 2017-06-02 | Multidirectional mucosal delivery devices and methods of use |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2020220105A Abandoned AU2020220105A1 (en) | 2008-06-23 | 2020-08-19 | Multidirectional mucosal delivery devices and methods of use |
Country Status (1)
Country | Link |
---|---|
AU (4) | AU2015203167A1 (en) |
-
2015
- 2015-06-04 AU AU2015203167A patent/AU2015203167A1/en not_active Abandoned
-
2017
- 2017-06-02 AU AU2017203749A patent/AU2017203749A1/en not_active Abandoned
-
2018
- 2018-11-07 AU AU2018260865A patent/AU2018260865A1/en not_active Abandoned
-
2020
- 2020-08-19 AU AU2020220105A patent/AU2020220105A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2020220105A1 (en) | 2020-09-03 |
AU2015203167A1 (en) | 2015-07-02 |
AU2017203749A1 (en) | 2017-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0915386B8 (en) | Device for delivering an active agent through the mucosa | |
WO2008011194A3 (en) | Transmucosal delivery devices with enhanced uptake | |
WO2007125545A3 (en) | Transmucosal composition | |
UA88464C2 (en) | Method of topical methadone administration providing systemic effect | |
NZ586588A (en) | Formulation of ( follice stimulating hormone) fsh and varients with benzalkonium chloride and benzyl alcohol | |
MX2010004265A (en) | Composition for administering an active ingredient and method for making and using the same. | |
WO2007070632A3 (en) | Abuse resistant transmucosal drug delivery device | |
WO2008146178A3 (en) | A novel tablet dosage form | |
WO2014186742A3 (en) | Anhydrous hydrogel composition | |
MX2012003082A (en) | Pharmaceutical compositions for reducing alcohol-induced dose dumping. | |
WO2010042471A3 (en) | Medical devices for delivery of therapeutic agents to body lumens | |
ATE474564T1 (en) | SMALL VOLUME, ORAL, TRANSMUCOSAL DOSAGE FORMS OF SUFENTANIL FOR PAIN TREATMENT | |
MX2009000730A (en) | Controlled release formulations and associated methods. | |
WO2010070675A3 (en) | Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof | |
PL2081547T3 (en) | Galenic form for the trans-mucosal delivery of active ingredients | |
WO2007143155A3 (en) | Sustained release pharmaceutical dosage form containing phenylephrine | |
WO2010121177A3 (en) | Pharmaceutically active compositions comprising oxidative stress modulators (osm), new chemical entities, compositions and uses | |
MY163809A (en) | Transdermal drug delivery system containing donepezil | |
WO2014130866A3 (en) | Targeted buccal delivery comprising cisplatin-loaded chitosan nanoparticles | |
CL2011003327A1 (en) | Pharmaceutical composition comprising finafloxacin and an anti-inflammatory agent; use in the treatment of ophthalmic, otic or nasal infections. | |
IL192611A0 (en) | Biologically active composition comprising ethylcellulose | |
MX2015007678A (en) | Transmucosal delivery of glatiramer acetate. | |
WO2011140446A3 (en) | Pharmaceutical formulations | |
WO2010019611A3 (en) | Bridged polycyclic compound based compositions for topical and oral applications | |
WO2014100643A8 (en) | Oral transmucosal delivery of glatiramer acetate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |